Journal of Psychoactive Drugs 2006: Vol 38 Index

2006·2.1 MB·English

Index
Volume 38 (1-4), 2006
AUTHORS
Ahrens, Katherine SARC 3: 377-83. Evren, Cuneyt 38 (1): 57-64.
Anderson, Kristen G. 38 (3): 255-62. Falck, Russel S. 38 (1): 19-29.
Ang-Lee, Kathleen 38 (4): 505-12. Feigelman, William 38 (2): 133-41.
Anglin, M. Douglas SARC 3: 415-26. Finigan, Michael SARC 3: 345-56.
Astone-Twerell, Janetta M. 38 (3): 233-41. Flaherty, Bruce 38 (4): 421-31.
Barendregt, Cas 38 (1): 77-89; 38 (2): 123-32. Freese, Thomas SARC 3: 321-22.
Barut, Tuncay 38 (1): 57-64. Furst, R. Terry 38 (2): 173-88.
Battisti, Murilo Campos 38 (1): 13-18. Gabriel, Roy M. 38 (4): 473-81.
Bennett, Trevor 38 (3): 243-54. Galanter, Marc 38 (4): 531-33.
Bluthenthal, Ricky N. 38 (4): 461-71. Gallon, Steven L. 38 (4): 473-81.
Booth, Brenda M. SARC 3: 393-404. Galloway, Gantt P. 38 (2): 189-202.
Boyd, Carol J. 38 (1): 43-56. Glickman, Linda 38 (4): 531-33.
Brecht, Mary-Lynn SARC 3: 415-26. Goldstein, Marjorie F. 38 (1): 93-100.
Bruehl, Alexandra M. SARC 3: 385-92. Grant, Igor SARC 3: 405-13.
Breslin, Kathy T. 38 (2): 157-60. Greenstein, Robert 38 (2): 149-56.
Brown, Michelle 38 (2): 189-202. Greenwell, Lisa SARC 3: 415-26.
Brown, Sandra A. 38 (3): 255-62. Hagan, Holly 38 (3): 233-41.
Burdon, William SARC 3: 333-43. Hallstone, Michael 38 (1): 65-75.
Byqvist, Siv 38 (4): 427-40. Harding, Brian 38 (3): 263-72.
Cakmak, Duran 38 (1): 57-64. Hastings, Arthur 38 (3): 273-83.
Carey, Shannon M. SARC 3: 345-56. Hjord, Hanna SARC 3: 377-83.
Carlini, Elisaldo de Aratijo 38 (1): 13-18; 38 (3): 285-95. Holloway, Katy 38 (3): 243-54.
Carlson, Robert G. 38 (1): 19-29; SARC 3: 393-404. Hong, Xiao 38 (2): 203-05.
Cepeda, Alice 38 (2): 109-21. Houston, Hank 38 (4): 483-91.
Christian, Darrell 38 (2): 189-202. Hunt, Kirsten 38 (2): 173-88.
Cook, Joan M. 38 (1): 89-92; 38 (2): 149-56. Hunter, Tracy S. 38 (3) : 229-32.
Coumans, Moniek 38 (2): 161-71. Inciardi, James A. 38 (3): 305-10.
Crumpton, Dave SARC 3: 345-56. Jacobucci, Raymond 38 (4): 483-91.
Dannaway, Frederick R. 38 (4): 493-503. Jaffe, Craig 38 (4): 505-12.
da Silva, Elisabeth Meyer 38 (3): 305-10. Jansen, Karl L.R. 38 (1): 1-12.
Davis, Kristin E. 38 (3): 263-72. Jaycox, Lisa H. 38 (4): 461-71.
Demir, Turkay 38 (3): 297-304. Kane, Vincent 38 (1): 89-92.; 38 (2): 149-56.
Deren, Sherry 38 (1): 93-100. Kaplan, Charles D. 38 (2): 109-21.
Dermatis, Helen 38 (4): 531-33. Kayman, Deborah J. 38 (1): 93-100.
Des Jarlais, Don C. 38 (3): 233-41. Kessler, Felix. 38 (3): 305-10.
Devitt, Timothy 38 (3): 263-72. Klausner, Jeffrey D. SARC 3: 377-83.
Didcott, Peter 38 (4): 421-31. Knibbe, Ronald A. 38 (2): 161-71.
Dingle, Shannon 38 (4): 531-33. Knox, Patricia C. 38 (4): 505-12.
Dobkin De Rios, Marlene 38 (3): 317-19. Knudsen, Jeffrey R.W. 38 (4): 473-81.
Elifson, Kirk SARC 3: 385-92. Krietemeyer, Jennifer 38 (4): 441-48.
Ellis, Mei Ling K. C. 38 (4): 505-12. Lafferty, Lynn 38 (3) : 229-32.
Evans, Elizabeth SARC 3: 357-67. Lanying, Lu 38 (2): 203-05.
Journal of Psychoactive Drugs Volume 38 (4), December 2006
Volume 38 (2006)
Latowsky, Mark 38 (4): 513-19. Shoptaw, Steven SARC 3: 377-83.
Lee, Julia A. 38 (2): 133-41. Siegal, Harvey A. 38 (1): 19-29.
Lende, Daniel H. SARC 3: 385-92. Simons, Lori 38 (4): 483-91.
Leukefeld, Carl G. SARC 3: 393-404; 38 (4): 441-48. Smith, David E. 38 (4): 535-36.
Lerner, Michael 38 (2): 143-47. So, Dominicus W. 38 (1): 35-42.
Liman, Olcay 38 (3): 297-304. Stalcup, Janice 38 (2): 189-202.
Longshore, Douglas SARC 3: 357-67. Stalcup, S. Alex 38 (2): 189-202.
Lucchini, Alfio 38 (3): 211-17. Staton-Tindall, Michele 38 (4): 441-48.
Lyvers, Michael 38 (2): 143-47. Sterk, Claire E. SARC 3: 385-92.
McCabe, Sean Esteban 38 (1): 43-56. Strauss, Shiela M. 38 (3): 233-41.
McCright, Jacque SARC 3: 377-83. Strona, Frank V. SARC 3: 377-83.
Malone, Sandra 38 (2): 157-60. Surratt, Hilary L. 38 (3): 305-10.
Malte, Carol A. 38 (4): 505-12. Taner, Sevil 38 (3): 297-304.
Mandal, Manas. K. 38 (1): 107-08. Teter, Christian J. 38 (1): 43-56.
Manzato, Ezio 38 (3): 211-17. Theron, Lynn 38 (1): 1-12.
Marsh, Wallace A. 38 (3) : 229-32. Thompson, Richard 38 (2): 149-56.
Martin, Steven S. 38 (3): 305-10. Tierney, Steven SARC 3: 377-83.
Mateyoke-Scrivner, Allison 38 (4): 441-48. Tosun, Musa 38 (3): 297-304.
Meredith, Charles 38 (4): 505-12. Urada, Darren SARC 3: 357-67.
Messina, Nena SARC 3: 333-43. Valdez, Avelardo 38 (2): 109-21.
Montoya, Isaac D. 38 (3):219-28. van de Mheen, Dike 38 (1): 77-89; 38 (2): 123-32, 161-71.
Morral, Andrew 38 (4): 461-71. van der Poel, Agnes 38 (1): 77-89; 38 (2): 123-32.
Munoz-Plaza, Corrine E. 38 (3): 233-41. von Diemen, Lisia 38 (3): 305-10.
Nappo, Solange 38 (1): 13-18. von Mayrhauser, Christina SARC 3: 415-26.
Nava, Felice 38 (3): 211-17. Walker, Patricia 38 (2): 149-56.
Noto, Ana Regina 38 (1): 13-18. Waller, Mark SARC 3: 345-56.
Ogel, Kiiltegin 38 (3): 297-304. Walser, Robyn D. 38 (1): 89-92.
O’ Neill, Sheila 38 (3): 263-72. Wang, Jichuan 38 (1): 19-29.
Oreskovich, Michael R. 38 (4): 505-12. Webster, J. Matthew 38 (4): 441-48.
Ott, Jonathan 38 (1): 101-05. Webster, Peter 38 (4): 493-503.
Passey, Megan 38 (4): 421-31. Weihua, Wang 38 (2): 203-05.
Pathak, Kripa S. 38 (1): 107-08. Wish, Eric D. 38 (1): 31-34; 38 (2): 207-10.
Patterson, Thomas L. SARC 3: 405-13. Wong, Frank Y. 38 (1): 35-42.
Pavick, Debra 38 (3): 263-72. Woody, George 38 (1): 89-92, 38 (2): 149-56.
Pechansky, Flavio 38 (3): 305-10. Yacoubian, Jr., George S. 38 (1): 31-34; 38 (2): 207-10.
Piper, Alan 38 (4): 493-503.
Premi, Stefania 38 (3): 211-17.
Prendergast, Michael SARC 3: 333-43, 357-67.
Rai, Shusheela 38 (1): 107-08.
Ramo, Danielle E. 38 (3): 255-62 ADOLESCENTS
Rawson, Richard SARC 3: 321-22. Juvenile offences among hospitalized adolescent inhalant
Richter, Kimber P. 38 (3): 311-15. users in Istanbul: A comparison regarding place of residence.
Riehman, Kara 38 (4): 461-71. Ogel, K.; Taner, S.; Tosun, M.; Liman, O. & Demir, T. 38
Rodrigues, Eliana 38 (3): 285-95. (3): 297-304.
Rollins, Angela 38 (3): 263-72. Life stress, coping and comorbid youth: An examination of
Rosen, Paul J. 38 (4): 441-48. the stress-vulnerability model for substance relapse. Ander-
Rosenblum, Andrew 38 (1): 93-100. son, K.G.; Ramo, D.E. & Brown, S.A. 38 (3): 255-62.
Rutkowski, Beth SARC 3: 321-22, 369-75. Perspectives on therapeutic treatment from adolescent pro-
Ruzek, Josef I. 38 (1): 89-92. bationers. Bluthenthal, R.N.; Riehman, K.; Jaycox, L.H. &
Saatcioglu Omer 38 (1): 57-64. Morral, A. 38 (4): 461-71.
Saxon, Andrew J. 38 (4): 505-12.
Schwartz, Melissa SARC 3: 385-92. AIDS
Semple, Shirley J. SARC 3: 405-13. Changing patterns of cocaine use and HIV risks in the south
Sexton, Rocky L. SARC 3: 393-404. of Brazil. Inciardi, J.A.; Surratt, H.L.; Pechansky, F.; Kessler, F.;
Sharma, Hari O. 38 (1): 107-08. von Diemen, L.; da Silva, EM. & Martin, S.S. 38 (3): 305-10.
Journal of Psychoactive Drugs Volume 38 (4), December 2006
Volume 38 (2006)
Perceived behavior of others and AIDS risk behavior among Prison-based treatment for drug-dependent women offenders:
heterosexually-identified methamphetamine users. Semple, Treatment versus no treatment. Messina, N.; Burdon, W. &
S.J.; Grant, I. & Patterson, T.L. SARC 3: 405-13. Prendergast, M. SARC 3: 333-43.
Variations in drug users’ accounts of the connection between
ALCOHOL drug misuse and crime. Bennett, T. & Holloway, K. 38 (3):
Alcohol, drugs, and substance use among Asian-American 243-54.
college students. So, D.W. & Wong, F.-Y. 38 (1):-35-42.
Comparing treatments of alcoholism on craving and bio- DRUG RESEARCH AND POLICY
chemical measures of alcohol consumptions. Nava, F.; Editors’ introduction: California Substance Abuse Research
Premi, S.; Manzato, E. & Lucchini, A. 38 (3): 211-17. Consortium, September 2005. Rutkowski, B.; Freese, T. &
Rawson, R. SARC 3: 321-22.
BOOK REVIEW A select annotated bibliography: Illegal drug research in
Ecstasy: In and About Altered States. Reviewed by Dobkin rural and suburban areas. Hunt, K. & Furst, R.T. 38 (2):
De Rios, Marlene 38 (3): 317-19. 173-88.
Street-level effects of local drug policy on marginalization
COCAINE and hardening: An ethnographic study among chronic drug
Changing patterns of cocaine use and HIV risks in the south users. Coumans, M.; Knibbe, R.A. & van de Mheen, D. 38
of Brazil. Inciardi, J.A.; Surratt, H.L.; Pechansky, F.; Kes- (2): 161-71.
sler, F., von Diemen, L.; da Silva, E.M. & Martin, S.S. 38 An upper/downer perfect storm: The coming world-wide
(3): 305-10. drug epidemic. Smith, D.E. 38 (4): 535-36.
CRAVING DRUG TESTING
Comparing treatments of alcoholism on craving and bio- A comparison between instant and laboratory oral fluid
chemical measures of alcohol consumptions. Nava, F.; analysis among arrestees. Yacoubian, Jr.,G.S. & Wish, E.D.
Premi, S.; Manzato, E. & Lucchini,A . 38 (3): 211-17. 38 (2): 207-10.
Craving and control: Methamphetamine users’ narratives.
Bruehl, A.M.; Lende, D.H.; Schwartz, M.; Sterk, C.E. & DUAL DIGANOSIS
Elifson, K. SARC 3: 385-92. Axis I psychiatric comorbidity among adult inhalant depen-
A treatment model for craving identification and manage- dents seeking treatment. Evren, C.; Barut, T.; Saatcioglu O.
ment. Stalcup, S.A.; Christian, D.; Stalcup, J.; Brown, M. & Cakmak, D. 38 (1): 57-64.
& Galloway, G.P. 38 (2): 189-202. Integrated cognitive behavioral therapy versus Twelve-Step
facilitation therapy for substance-dependent adults with
CRIMINAL JUSTICE depressive disorders. Brown, S.A.; Glasner-Edwards, S.V.;
California drug courts: Outcomes, costs and promising Tate, S.R.; McQuaid, J.R.; Chalekian, J. & Granholm, E.
practices: An overview of Phase II in a statewide study. 38 (4): 449-60.
Carey, S.M.; Finigan, M.; Crumpton, D. & Waller, M.S ARC Integrated residential treatment for persons with severe and
3: 345-56. persistent mental illness: Lessons in recovery. Davis, K.E.;
Evaluation of the Substance Abuse and Crime Preven- Devitt, T.; Rollins, A.; O’Neill, S.; Pavick, D. & Harding,
tion Act: Client characteristics, treatment completion and B. 38 (3): 263-72.
re-offending three years after implementation. Evans, E.; Psychiatric disorders and their correlates among young adult
Longshore, D.; Prendergast, M. & Urada, D. SARC 3: 357-67. MDMA users in Ohio. Falck, R.S.; Carlson, R.G.; Wang, J.
Gender, mental health, and treatment motivation in a drug & Siegal, H.A. 38 (1): 19-29.
court setting. Webster, J.M.; Rosen, P.J.; Krietemeyer, J.;
Mateyoke-Scrivner, A.; Staton-Tindall, M. & Leukefeld, HEPATITIS C
C. 38 (4): 441-48. Staff perspectives on facilitating the implementation of hepa-
Judicial supervision of drug-abusing offenders. Marlowe, titis C services at drug treatment programs. Munoz-Plaza,
D.B. SARC 3: 323-31. C.E.; Strauss, S.M.; Astone-Twerell, J.M.; Des Jarlais,
Juvenile offences among hospitalized adolescent inhalant D.C. & Hagan, H. 38 (3): 233-41.
users in Istanbul: A comparison regarding place of residence.
Ogel, K.; Taner, S.; Tosun, M.; Liman, O. & Demir, T. 38 INHALANTS
(3): 297-304. Axis I psychiatric comorbidity among adult inhalant depen-
The Magistrates Early Referral into Treatment (MERIT) dents seeking treatment. Evren, C.; Barut, T.; Saatcioglu O.
Pilot Program: A Descriptive Analysis of a Court Diver- & Cakmak, D. 38 (1): 57-64.
sion Program in Rural Australia. Passey, M.; Flaherty, B. Juvenile offences among hospitalized adolescent inhalant
& Didcott, P. 38 (4): 421-31. users in Istanbul: A comparison regarding place of residence.
Journal of Psychoactive Drugs Volume 38 (4), December 2006
Volume 38 (2006)
Ogel, K.; Taner, S.; Tosun, M.; Liman, O. & Demir, T. 38 Methamphetamine use and adverse consequences in the
(3): 297-304. rural Southern United States: An ethnographic overview.
Sexton, R.L.; Carlson, R.G.; Leukefeld, C.G. & Booth,
MARIJUANA B.M. SARC 3: 393-404.
An exploratory investigation of marijuana and other drug Perceived behavior of others and AIDS risk behavior among
careers. Hallstone, M. 38 (1): 65-75 heterosexually-identified methamphetamine users. Semple,
S.J.; Grant, I. & PattersonT,.L . SARC 3: 405-13.
MDMA I'wo-year outcomes of treatment for methamphetamine use.
Ecstasy (MDMA), methamphetamine, and date rape (drug- Brecht, M.-L.; Greenwell, L.; von Mayrhauser, C. & Anglin,
facilitated sexual assault): A consideration of the issues. M.D. SARC 3: 415-26.
Jansen, K.L.R. & Theron, L. 38 (1): 1-12.
Exploring the validity of self-reported Ecstasy use among NALTREXONE
club rave attendees. Yacoubian, Jr., G.S. & Wish, E.D. 38 Obviation of opioid withdrawal syndrome by concomitant
(1): 31-34. administration of naltrexone in microgram doses: Two
An extended nondrug MDMA-like experience evoked psychonautic bioassays. Ott, J. 38 (1): 101-05.
through posthypnotic suggestion. Hastings, A. 38 (3):
273-83. OPIOIDS
A profile of Ecstasy (MDMA) use in Sao Paulo, Brazil: An Case-control retrospective study of pulmonary tuberculosis
ethnographic study. Battisti, M.C.; Noto, A.R.; Nappo, S in heroin-abusing patients in China. Weihua, W.; Hong, X.
& Carlini, E. 38 (1): 13-18. & Lanying, L. 38 (2): 203-05.
Psychiatric disorders and their correlates among young adult Heroin addicts show impairment of information processing
MDMA users in Ohio. Falck, R.S.; Carlson, R.G.; Wang, J at the iconic level. Pathak, K.S.; Mandal, M.K.; Sharma,
& Siegal, H.A. 38 (1): 19-29. H.O. & Rai, S. 38 (1): 107-08.
Obviation of opioid withdrawal syndrome by concomitant
METHADONE administration of naltrexone in microgram doses: Two
Maintaining the viability and safety of the methadone psychonautic bioassays. Ott, J. 38 (1): 101-05.
maintenance treatment program. Breslin, K.T. & Malone, The rise of the mobile phone in the hard drug scene of Rot-
S. 38 (2): 157-60. terdam. Barendregt, C.; van der Poel, A. & van de Mheen,
Methadone death, dosage and torsade de pointes: Risk-ben- D. 38 (1): 77-89.
efit policy implications. Latowsky, M. 38 (4): 513-19. Single dose of 24 milligrams of buprenorphine for heroin
Predicting treatment retention with a brief “Opinions About detoxification: An open-label study of five inpatients. Ang-
Methadone” scale. Kayman, D.J.; Goldstein, M.F.; Deren, Lee, K.; Oreskovich, M.R.; Saxon, A.J.; Jaffe, C.; Meredith, C.;
S. & Rosenblum, A. 38 (1): 93-100. Ellis, M.L.K.; Malte, C.A. & Knox, P.C. 38 (4): 505-12.
Recovery and spiritual transformation among peer leaders Suicidal ideation in veterans receiving treatment for opiate
of a modified Methadone Anonymous group. Glickman, L.; dependence. Thompson, R.; Kane, V.; Cook, J.M.; Green-
Galanter, M.; Dermatis, H. & Dingle, S. 38 (4): 531-33. stein, R.; Walker, P. & Woody, G. 38 (2): 149-56.
METHAMPHETAMINE PRESCRIPTION DRUGS
rhe acceptability and feasibility of the Positive Reinforce- Knowledge, attitudes and practices of pharmacists concern-
ment Opportunity Project, a community-based contingency ing prescription drug abuse. Lafferty, L.; Hunter, T.S. &
management methamphetamine treatment program for gay Marsh, W.A. 38 (3): 229-32.
and bisexual men in San Francisco. Strona, F.V.; McCright,J. ; Medical use, illicit use and diversion of prescription stimu-
Hjord, H.; Ahrens, K.; Tierney, S.; Shoptaw, S. & Klausner, lant medication. McCabe, S.E.; Teter, C.J. & Boyd, C.J. 38
J.D. SARC 3: 377-83. (1): 43-56.
California Substance Abuse Research Consortium, Septem-
ber 2005: Update on recent methamphetamine trends in four PSYCHEDELIC DRUGS
California regions. Rutkowski, B.A. SARC 3: 369-75. Bread of heaven or wines of light: Entheogenic legacies and
Craving and control: Methamphetamine users’ narratives. esoteric cosmologies. Dannaway, F.R.; Piper, A. & Webster,
Bruehl, A.M.; Lende, D.H.; Schwartz, M.; Sterk, C.E. & P. 38 (4): 493-503.
Elifson, K. SARC 3: 385-92. A comparison of plants utilized in ritual healing by two Bra-
Ecstasy (MDMA), methamphetamine, and date rape (drug- zilian cultures: Quilombolas and Krahé Indians. Rodrigues,
facilitated sexual assault): A consideration of the issues. E. & Carlini, E.A. 38 (3): 285-95.
Jansen, K.L.R. & Theron, L. 38 (1): 1-12.
Journal of Psychoactive Drugs Volume 38 (4), December 2006
Volume 38 (2006)
Values and beliefs of psychedelic drug users: A cross-cultural Integrated residential treatment for persons with severe and
study. Lerner, M. & Lyvers, M. 38 (2): 143-47. persistent mental illness: Lessons in recovery. Davis, K.E.;
Devitt, T.; Rollins, A.; O'Neill, S.; Pavick, D. & Harding,
RECOVERY B. 38 (3): 263-72.
Recovery and spiritual transformation among peer leaders Maintaining the viability and safety of the methadone
of a modified Methadone Anonymous group. Glickman, L.; maintenance treatment program. Breslin, K.T. & Malone,
Galanter, M.; Dermatis, H. & Dingle, S. 38 (4): 531-33. S. 38 (2): 157-60.
Novice, seasoned and veteran counselors’ views of addiction
TOBACCO treatment manuals: The influence of counselor character-
Are Americans receptive to smokefree bars? Feigelman, W. istics on manual usefulness. Simons, L.; Jacobucci, R. &
& Lee, J.A. 38 (2): 133-41. Houston, H. 38 (4): 483-91.
Good and bad times for treating cigarette smoking in drug Perspectives on therapeutic treatment from adolescent pro-
treatment. Richter, K.P. 38 (3): 311-15. bationers. Bluthenthal, R.N.; Riehman, K.; Jaycox, L.H. &
Morral, A. 38 (4): 461-71.
TREATMENT Predicting treatment retention with a brief “Opinions About
The acceptability and feasibility of the Positive Reinforce- Methadone” scale. Kayman, D.J.; Goldstein, M.F.; Deren,
ment Opportunity Project, a community-based contingency S. & Rosenblum, A. 38 (1): 93-100.
management methamphetamine treatment program for gay Relating substance abuse counselor background to the
and bisexual men in San Francisco. Strona, F.V.; McCright, J.; provision of clinical tasks. Knudsen, J.R.W.; Gallon, S.L.
Hjord, H.; Ahrens, K.; Tierney, S.; Shoptaw, S. & Klausner, & Gabriel, R.M. 38 (4): 473-81.
J.D. SARC 3: 377-83. Staff perspectives on facilitating the implementation of hepa-
Comparing treatments of alcoholism on craving and bio- titis C services at drug treatment programs. Munoz-Plaza,
chemical measures of alcohol consumptions. Nava, F.; C.E.; Strauss, S.M.; Astone-Twerell, J.M.; Des Jarlais,
Premi, S.; Manzato, E. & Lucchini,A . 38 (3): 211-17. D.C. & Hagan, H. 38 (3): 233-41.
Differences in drug treatment services based on profit status. Suicidal ideation in veterans receiving treatment for opiate
Montoya, I.D. 38 (3):219-28. dependence. Thompson, R.; Kane, V.; Cook, J.M.; Green-
Dissemination and feasibility of a cognitive-behavioral treat- stein, R.; Walker, P. & Woody, G. 38 (2): 149-56.
ment for substance use disorders and posttraumatic stress A treatment model for craving identification and manage-
disorder in the Veterans Administration. Cook, J.M.; Walser, ment. Stalcup, S.A.; Christian, D.; Stalcup, J.; Brown, M.
R.D.; Kane, V.; Ruzek, J.I. & Woody, G. 38 (1): 89-92. & Galloway, G.P. 38 (2): 189-202.
Drug users’ participation in addiction care: Different groups
do different things. van der Poel, A.; Barendregt, C. & van VIOLENCE
de Mheen, D. 38 (2): 123-32. The drugs-violence nexus among Mexican-American gang
Gender, mental health, and treatment motivation in a drug members. Valdez, A.; Kaplan, C.D. & Cepeda, A. 38 (2):
court setting. Webster, J.M.; Rosen, P.J.; Krietemeyer, J.; 109-21.
Mateyoke-Scrivner, A.; Staton-Tindali, M. & Leukefeld,
C. 38 (4): 441-48. WOMEN
Good and bad times for treating cigarette smoking in drug Drug-abusing women in Sweden: Marginalization, social
treatment. Richter, K.P. 38 (3): 311-15. exclusion and gender differences. Byqvist, S. 38 (4): 427-
Integrated cognitive behavioral therapy versus Twelve-Step 40.
facilitation therapy for substance-dependent adults with Prison-based treatment for drug-dependent women offenders:
depressive disorders. Brown, S.A.; Glasner-Edwards, S.V.; Treatment versus no treatment. Messina, N.; Burdon, W. &
Tate, S.R.; McQuaid, J.R.; Chalekian, J. & Granholm, E. Prendergast, M. SARC 3: 333-43.
38 (4): 449-60.
Journal of Psychoactive Drugs Volume 38 (4), December 2006

Pict
Ae